TY - CONF T1 - Treatment-Emergent Adverse Events in Patients Aged 6 Months to 5 Years With Moderate-to- Severe Atopic Dermatitis Treated With Dupilumab in an Open-Label Extension Clinical Trial JO - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY PY - 2023/01/01 AU - Paller A AU - Siegfried E AU - Sidbury R AU - Lockshin B AU - Cork M AU - Pinter A AU - Xiao J AU - Stanton S AU - Khokhar F AU - Bansal A AU - Prescilla R ED - VL - 89 IS - 3 SP - AB100 EP - AB100 Y2 - 2025/04/09 ER -